Publication | Closed Access
Quantitative assessment of spironolactone treatment in women with diffuse androgen-dependent alopecia
23
Citations
19
References
1990
Year
Diffuse Androgen-dependent AlopeciaHair QualityPharmacologyGynecologyTotal Hair DensityHair DensityDermatologyMedicineSpironolactone TreatmentQuantitative Assessment
months with spironolactone (75 or 100 mg per day) and six remained untreated. In the untreated (control) group, mean values for total hair density (P 150 mg per day may be necessary to improve hair quality and increase hair density. However, further long-term studies are required to confirm these findings.
| Year | Citations | |
|---|---|---|
Page 1
Page 1